Revvity Inc
NYSE:RVTY
Relative Value
The Relative Value of one RVTY stock under the Base Case scenario is 120.19 USD. Compared to the current market price of 108.32 USD, Revvity Inc is Undervalued by 10%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
RVTY Competitors Multiples
Revvity Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
R
|
Revvity Inc
NYSE:RVTY
|
13.4B USD | 4.9 | 89.4 | 21.2 | 55.3 | |
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
231.1B USD | 5.4 | 38.5 | 23.7 | 34.8 | ||
US |
Danaher Corp
NYSE:DHR
|
195.6B USD | 4.5 | 24.3 | 17.6 | 21.7 | ||
US |
Agilent Technologies Inc
NYSE:A
|
45.2B USD | 6.7 | 36.6 | 29.2 | 35.1 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
42.7B USD | 2.9 | 31.5 | 17 | 26.3 | ||
CH |
Lonza Group AG
SIX:LONN
|
38B CHF | 5.7 | 58.2 | 20 | 29.3 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
55.8T KRW | 15.1 | 65.1 | 34.3 | 49.4 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
32.6B USD | 8.6 | 41.9 | 28.5 | 31.7 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
26.2B USD | 3.2 | 38.3 | 17.3 | 26.5 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
25.9B USD | 8.8 | 45.5 | 31.5 | 38.3 | ||
US |
Waters Corp
NYSE:WAT
|
21.4B USD | 7.4 | 35.5 | 23.8 | 29.3 |